{"id":"NCT00929331","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity & Safety Study of Fluviral速 (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral速 (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-07-11","primaryCompletion":"2009-08-01","completion":"2009-08-01","firstPosted":"2009-06-29","resultsPosted":"2010-08-13","lastUpdate":"2020-11-09"},"enrollment":110,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza, Human"],"interventions":[{"type":"BIOLOGICAL","name":"Fluviral速","otherNames":[]}],"arms":[{"label":"Fluviral Adult Group","type":"EXPERIMENTAL"},{"label":"Fluviral Elderly Group","type":"EXPERIMENTAL"}],"summary":"This study is designed to test the safety and immunogenicity of Fluviral速 (2009 - 2010 Season) in adults aged 18 to 60 years and over 60 years.","primaryOutcome":{"measure":"Geometric Mean Titers (GMTs) of Hemagglutination Inhibition (HI) Antibodies","timeFrame":"At Day 0","effectByArm":[{"arm":"Fluviral Adult Group","deltaMin":27.2,"sd":null},{"arm":"Fluviral Elderly Group","deltaMin":22.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":21},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":55},"commonTop":["Pain","Fatigue","Muscle aches","Headache","chills"]}}